mitoxantrone has been researched along with Carotid Stenosis in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dirsch, O | 1 |
| Dahmen, U | 1 |
| Gu, YL | 1 |
| Ji, Y | 1 |
| Karoussos, IA | 1 |
| Wieneke, H | 1 |
| Erbel, R | 1 |
1 other study available for mitoxantrone and Carotid Stenosis
| Article | Year |
|---|---|
Preliminary investigation of mitoxantrone coating on stent-grafts to inhibit neointimal proliferation.
Topics: Animals; Biopsy, Needle; Carotid Stenosis; Catheterization; Cell Proliferation; Coated Materials, Bi | 2005 |